Vopratelimab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Vopratelimab, covering 2022-09-10 to 2024-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Vopratelimab (JTX-2011) Alone and in Combination With Anti-Programmed Cell Death Protein 1 (PD-1) or Anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) in Subjects With Advanced and/or Refractory Solid Tumors [Phase 1, Phase 2]